27476541|t|Studying neuroprotective effect of Atorvastatin as a small molecule drug on high glucose - induced neurotoxicity in undifferentiated PC12 cells: role of NADPH oxidase
27476541|a|Overproduction of reactive oxygen species (ROS) by NADPH oxidase (NOX) activation has been considered the essential mechanism induced by hyperglycemia in various tissues. However, there is no comprehensive study on the role of NOXs in high glucose (HG)- induced toxic effect in neural tissues. Recently, a therapeutic strategy in oxidative related pathologies has been introduced by blocking the undesirable actions of NOX enzymes by small molecules. The protective roles of Statins in ameliorating oxidative stress by NOX inhibition have been shown in some tissues except neural. We hypothesized then, that different NOXs may have role in HG - induced neural cell injury. Furthermore, we postulate that Atorvastatin as a small molecule may modulate this NOXs activity to protect neural cells. Undifferentiated PC12 cells were treated with HG (140 mM/ 24 h) in the presence and absence of Atorvastatin (1 Î¼M/ 96 h). The cell viability was measured by MTT assay and the gene and protein expressions profile of NOX (1-4) were determined by RT-PCR and western blotting, respectively. Levels of ROS and malondialdehyde (MDA) were also evaluated. Gene and protein expression levels of NOX (1-4) and consequently ROS and MDA levels were elevated in HG - treated PC12 cells. Atorvastatin could significantly decrease HG - induced NOXs, ROS and MDA elevation and improve impaired cell viability. It can be concluded that HG could elevate NOXs activity, ROS and MDA levels in neural tissues and Atorvastatin as a small molecule NOX inhibitor drug may prevent and delay diabetic complications, particularly neuropathy.
27476541	0	8	Studying	T062	C0681814
27476541	9	31	neuroprotective effect	T169	C0815279
27476541	35	47	Atorvastatin	T109,T121	C0286651
27476541	53	67	small molecule	T109	C1328819
27476541	68	72	drug	T121	C1254351
27476541	76	88	high glucose	T033	C0860803
27476541	91	98	induced	T169	C0205263
27476541	99	112	neurotoxicity	T037	C0235032
27476541	116	132	undifferentiated	T080	C0205618
27476541	133	143	PC12 cells	T025	C0085262
27476541	145	149	role	T077	C1705810
27476541	153	166	NADPH oxidase	T116,T126	C0068355
27476541	167	181	Overproduction	T080	C0205556
27476541	185	208	reactive oxygen species	T123,T196	C0162772
27476541	210	213	ROS	T123,T196	C0162772
27476541	218	231	NADPH oxidase	T116,T126	C0068355
27476541	233	236	NOX	T116,T126	C0068355
27476541	238	248	activation	T044	C0014429
27476541	258	268	considered	T078	C0750591
27476541	273	282	essential	T080	C0205224
27476541	283	292	mechanism	T169	C0441712
27476541	293	300	induced	T169	C0205263
27476541	304	317	hyperglycemia	T047	C0020456
27476541	329	336	tissues	T024	C0040300
27476541	356	372	no comprehensive	T080	C0205556
27476541	373	378	study	T062	C0681814
27476541	386	390	role	T077	C1705810
27476541	394	398	NOXs	T116,T126	C0068355
27476541	402	414	high glucose	T033	C0860803
27476541	416	418	HG	T033	C0860803
27476541	421	428	induced	T169	C0205263
27476541	429	441	toxic effect	T037	C0600688
27476541	445	459	neural tissues	T024	C0027757
27476541	473	484	therapeutic	T169	C0302350
27476541	485	493	strategy	T041	C0679199
27476541	497	506	oxidative	T169	C0311404
27476541	507	514	related	T080	C0439849
27476541	515	526	pathologies	T091	C0030664
27476541	536	546	introduced	T169	C1292748
27476541	550	558	blocking	T169	C0332206
27476541	563	582	undesirable actions	T052	C3266814
27476541	586	597	NOX enzymes	T116,T126	C0068355
27476541	601	616	small molecules	T109	C1328819
27476541	622	632	protective	T033	C1545588
27476541	633	638	roles	T077	C1705810
27476541	642	649	Statins	T109,T121	C0360714
27476541	653	665	ameliorating	T080	C0205556
27476541	666	682	oxidative stress	T049	C0242606
27476541	686	689	NOX	T116,T126	C0068355
27476541	690	700	inhibition	T039	C1524081
27476541	725	732	tissues	T024	C0040300
27476541	740	746	neural	T024	C0027757
27476541	751	763	hypothesized	T078	C1512571
27476541	775	784	different	T080	C1705242
27476541	785	789	NOXs	T116,T126	C0068355
27476541	799	803	role	T077	C1705810
27476541	807	809	HG	T033	C0860803
27476541	812	819	induced	T169	C0205263
27476541	820	838	neural cell injury	T049	C0599732
27476541	856	865	postulate	T078	C1705535
27476541	871	883	Atorvastatin	T109,T121	C0286651
27476541	889	903	small molecule	T109	C1328819
27476541	908	916	modulate	T082	C0443264
27476541	922	935	NOXs activity	T044	C1151146
27476541	939	946	protect	T033	C1545588
27476541	947	959	neural cells	T025	C0027882
27476541	961	977	Undifferentiated	T080	C0205618
27476541	978	988	PC12 cells	T025	C0085262
27476541	994	1006	treated with	T061	C0332293
27476541	1007	1009	HG	T033	C0860803
27476541	1019	1023	24 h	T079	C0456696
27476541	1032	1040	presence	T033	C0150312
27476541	1045	1052	absence	T169	C0332197
27476541	1056	1068	Atorvastatin	T109,T121	C0286651
27476541	1076	1080	96 h	T079	C0439227
27476541	1087	1101	cell viability	T043	C0007620
27476541	1106	1114	measured	T080	C0444706
27476541	1118	1127	MTT assay	T062	C2986858
27476541	1136	1140	gene	T081	C1956267
27476541	1145	1172	protein expressions profile	T034	C3463810
27476541	1176	1179	NOX	T116,T126	C0068355
27476541	1191	1204	determined by	T080	C0521095
27476541	1205	1211	RT-PCR	T063	C0599161
27476541	1216	1232	western blotting	T059,T063	C0005863
27476541	1248	1254	Levels	T080	C0441889
27476541	1258	1261	ROS	T123,T196	C0162772
27476541	1266	1281	malondialdehyde	T109,T123	C0024643
27476541	1283	1286	MDA	T109,T123	C0024643
27476541	1298	1307	evaluated	T052	C1516048
27476541	1309	1313	Gene	T045	C0017262
27476541	1318	1336	protein expression	T045	C1171362
27476541	1337	1343	levels	T080	C0441889
27476541	1347	1350	NOX	T116,T126	C0068355
27476541	1361	1373	consequently	T033	C3845876
27476541	1374	1377	ROS	T123,T196	C0162772
27476541	1382	1385	MDA	T109,T123	C0024643
27476541	1386	1392	levels	T080	C0441889
27476541	1398	1406	elevated	T080	C3163633
27476541	1410	1412	HG	T033	C0860803
27476541	1415	1422	treated	T169	C1522326
27476541	1423	1433	PC12 cells	T025	C0085262
27476541	1435	1447	Atorvastatin	T109,T121	C0286651
27476541	1454	1467	significantly	T078	C0750502
27476541	1468	1476	decrease	T081	C0547047
27476541	1477	1479	HG	T033	C0860803
27476541	1482	1489	induced	T169	C0205263
27476541	1490	1494	NOXs	T116,T126	C0068355
27476541	1496	1499	ROS	T123,T196	C0162772
27476541	1504	1507	MDA	T109,T123	C0024643
27476541	1508	1517	elevation	T082	C0702240
27476541	1522	1529	improve	T033	C0184511
27476541	1530	1538	impaired	T169	C0221099
27476541	1539	1553	cell viability	T043	C0007620
27476541	1565	1574	concluded	T078	C1707478
27476541	1580	1582	HG	T033	C0860803
27476541	1589	1596	elevate	T080	C3163633
27476541	1597	1610	NOXs activity	T044	C1151146
27476541	1612	1615	ROS	T123,T196	C0162772
27476541	1620	1623	MDA	T109,T123	C0024643
27476541	1624	1630	levels	T080	C0441889
27476541	1634	1648	neural tissues	T024	C0027757
27476541	1653	1665	Atorvastatin	T109,T121	C0286651
27476541	1671	1685	small molecule	T109	C1328819
27476541	1686	1704	NOX inhibitor drug	T121	C1254351
27476541	1709	1716	prevent	T080	C2700409
27476541	1721	1726	delay	T079	C0205421
27476541	1727	1749	diabetic complications	T047	C0342257
27476541	1764	1774	neuropathy	T047	C0442874